Prehypertension is known to be a risk factor for hypertension and cardiovascular disease. If prehypertension is left untreated, the blood pressure continues to increase due to multiple accelerators which facilitate the development of hypertension. Studies using animal models of hypertension suggested that interruption of these mechanisms by transient inhibition of the renin-angiotensin system (RAS) attenuates the development of hypertension. The TROPHY study provided clinical evidence that pharmacological intervention in the prehypertensive stage may suppress subsequent development of hypertension. Recently, we reported that high dose angiotensin inhibition in spontaneously hypertensive rats (SHR) with established hypertension caused a significant regression of hypertension, and we have started a prospective, multi-center clinical study (STAR CAST study) to examine if regression from hypertension back to prehypertension may also be feasible in humans. Since prehypertension is increasingly recognized as an important public health issue, further studies to assess strategies for attenuating the progression from prehypertension to hypertension are required.
Keywords: Prehypertension, high-normal blood pressure, pharmacological therapy, prevention, regression, eutrophic remodeling, chronic inflammation, hypertrophy, angiotensin receptor blockers, pharmacological agents
Pre-CKD- Do we Need Another Hero?
Current Vascular Pharmacology Hypertension, Prehypertension and Blood Pressure Related Diseases
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Under Re-organization) Endothelial Changes in Individuals with Prehypertension
Current Hypertension Reviews Cardiovascular Disease in Masked Hypertension: Clinical Implications
Current Hypertension Reviews Patients with Prehypertension - Do we have Enough Evidence to Treat them?
Current Vascular Pharmacology Is Hypertension an Inflammatory Process?
Current Pharmaceutical Design Endothelial Progenitor Cells in Prehypertension
Current Pharmaceutical Design Plasma Potassium Levels in Healthy Prehypertension Subjects and the Role of A High Potassium Drink
Current Hypertension Reviews Pharmacologic Treatment for Prehypertension: To Treat or Not to Treat?
Recent Patents on Cardiovascular Drug Discovery (Discontinued) Ambulatory Blood Pressure Monitoring in Prehypertensive Subjects
Cardiovascular & Hematological Disorders-Drug Targets Structural Alterations of the Retinal Microcirculation in the “Prehypertensive” High- Normal Blood Pressure State
Current Pharmaceutical Design